|[April 24, 2014]
NJOY Welcomes Proposed FDA Regulations for Electronic Cigarettes
SCOTTSDALE, Ariz. --(Business Wire)--
NJOY, the country's leading independent manufacturer of electronic
cigarettes, welcomed the U.S. Food and Drug Administration's (FDA)
issuance of proposed regulations for electronic cigarettes.
"We have long supported FDA regulation of electronic cigarettes, and
believe that the issuance of today's proposed regulations is a
critically important milestone," said Craig Weiss, NJOY's President and
CEO. "By resisting calls to regulate ahead of - and indeed in opposition
to - the science and data, today the FDA has brought NJOY a giant step
closer to achieving its corporate mission of obsoleting cigarettes.
There are encouraging signs that 10 years from now, this date will be
remembered as the beginning of the end of the tobacco epidemic."
Additionally,the chairman of NJOY's Scientific Advisory Board, the 17th
Surgeon General of the United States Dr. Richard Carmona, agreed that
well written FDA regulations could help reduce the incidence of tobacco
smoking in the United States and the health consequences that are
related to it.
"As it pertains to the public's health, it's important that the FDA -
and the public - recognize the inherent differences between traditional
cigarettes and e-cigarettes and these draft regulations are a good first
step," Dr. Carmona said. "Cigarettes have killed millions of Americans
and while smoking rates have decreased they have plateaued and still too
many adults and young people smoke today. By providing better
alternatives for nicotine delivery we can reduce the incidence of cancer
and heart disease and improve the health and well-being of Americans. I
remain committed to studying the health effects of e-cigarette use so
that we can all better understand the options for smoking cessation
NJOY indicated that the company would further review the proposed
regulations and looks forward to continued engagement in the regulatory
process regarding the content of the final regulations. "NJOY looks
forward to working with the FDA on establishing a reasonable,
responsible and uniform regulatory environment that facilitates the
achievement of NJOY's goal of obsoleting tobacco cigarettes, with the
potential for saving millions of American lives," Weiss said.
[ Back To Homepage ]